Clinical Trial Search

Primary: Kaplan-Meier Cumulative Incidence Rate of Major Adverse Cardiovascular Events — 10.17; 10.93 Percentage of Participants — p=0.3503

Primary: Adherence to Refills and Medications Scale (ARMS) — 12.03; 12.18 units on a scale

Primary: Low Density Lipoprotein - Cholesterol — -6.74; 0.53 mg/dL — p=0.27

Primary: Adherence to Cardioprotective Medications (Clopidogrel, Statins, Beta Blockers, ACE-inhibitor/ARB) — 89.3; 73.9 percentage of participants — p=0.003

Primary: Quality-Adjusted Life Years (QALYs) — -0.06; -0.06; -0.06 quality-adjusted life years (QALYs) — p=0.98

Primary: Cardiac Rehabilitation Attendance — 16.9; 12.0; 24.1; 10.9 sessions of CR

Primary: Rates of Major Cardiac Events (AMI or Cardiac Death) Within 30 Days — 0; 0; 0; 10 Participants

Primary: Acceptability as Measured by the Acceptability of Intervention Measure (AIM) — 4.82 score on a scale

Primary: Efficiency--Mean Cost of Care — 3933; 2761 US Dollars

Primary: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. — 51; 53 Participants

Primary: Attendance at Cardiac Rehabilitation Exercise Sessions — 36; 19 Participants

Primary: Acceptability Measured by the Client Satisfaction Questionnaire — 30.57 score on a scale

Primary: Test if Chest Pain Choice Safely Improves Patient Knowledge. — 4.2; 3.6 number of questions correct

Primary: The Composite Incidence of Death and Non-coronary Artery Bypass Graft (CABG) Major Bleeding — 5.1; 8.5 percentage of participants — p=0.0014

Primary: Total Mortality. — 138 Participants.

Primary: Feasibility as Measured by the Number of Total Scheduled Intervention Sessions (CHW Counseling Sessions, Doctor's Visits, Phone Calls) Attended — 589 Scheduled sessions

Primary: 1 -Year Survival Probability Rate: Vascular Readmissions or Death — .91; .91 proportion of participants

Primary: Percentage of Participants With a Composite Endpoint of Cardiovascular (CV) Death, Myocardial Infarction (MI), or Stroke — 10.06; 24.64; 10.96; 24.13 percentage of…

Primary: Primary Composite Outcome: Death From Cardiovascular Causes, Myocardial Infarction, or Hospitalization for Unstable Angina, Heart Failure, or Resuscitated Cardiac Arrest…

Primary: Myocardial Perfusion Reserve — 2.76; 2.47; 2.82; 2.52 Ratio

Primary: Platelet - Leukocyte Aggregates — 29.2; 39.8; 26.2; 21.1 % leukocytes with platelets attached

Primary: Percentage of Adherent Patients — 590; 4484; 2209; 3633 Participants

Primary: Percent Change in LDL-Cholesterol — -68.78; -27.58 percent change

Primary: Number of Participants With First Occurrence of Any Component of Composite MACE (CV Death, MI, or Stroke) — 439; 472 Participants — p=0.121

Primary: 30-day Composite Major Adverse Cardiac Event (MACE) — 256; 83 participants

Primary: Composite of Death, Myocardial (re-) Infarction, or Stroke — 153; 163 participants — p=0.15

Primary: Mean Change From Baseline to Week 4 in P2Y12 Reaction Units During Period 1 — -18.2 P2Y12 reaction unit

Primary: Achievement of LDL-cholesterol Goals — 31; 29 participants

Primary: Length of Hospital Stay — 7.63; 8.20 Hours — p=0.79

Primary: Number of Participants Who Are Successfully Enrolled Into the Pilot Study Per Month — 0.91 Participants enrolled per month